Beruflich Dokumente
Kultur Dokumente
Goals
Review ADA goals for blood glucose levels Importance of maintaining euglycemia Discuss why ISS is not acceptable for sole coverage Give options for insulin regimens Discuss inpatient education Discharge planning
This autopilot approach as the sole mode of treatment for inpatient hyperglycemia has been strongly condemned. Abourizk, N. Inpatient
Diabetology
Goals of Treatment
Safety
The fear of HYPOglycemia is a barrier to adequate care BUT HYPOglycemia is a major safety issue As orders become more complex, the risk of error increases
Need for protocols and system based approaches
Goals of Treatment
Glycemic Control upper limits
Intensive Care 110 mg/dL Non-Critical Care
Preprandial 110 mg/dL Post-Prandial / MAX 180 mg/dl
American College of Endocrinology. Position Statement on Inpatient Diabetes and Metabolic Control. Endocr Pract 2004; 10:77-82
Discharge Planning
Diet
Caloric intake Are they counting calories? Do they eat a regular diet?
Retinopathy Neuropathy
Labs
HgA1c Renal function
Inpatient Monitoring
Bedside glucose monitoring
At least QID (before meals and at HS) May obtain 3AM level If pt NPO check every 6 hours Continuous tube feedings check q 6 hours Bolus tube feedings check pre-feeding and 2 hours post- PM feeding (post prandial)
Inpatient Monitoring
Understand how your orders are followed
QID Accuchecks
Done at 600, 1100, 1600 and 2100 unless otherwise specified
Insulin Dosing
With meals 0800, 1200, 1700 HS = 2100
Biguanides (Metformin)
MOA: Decreases hepatic glucose output / increases peripheral glucose uptake Pros: May facilitate weight loss, does not cause hypoglycemia Cons:
Lactic Acidosis
Contrast media
Sulfonylureas
MOA: Close ATP / K+ channel in the Bcell Insulin release Cons:
Can cause hypoglycemia Metabolism affected by Renal / Hepatic impairment Glyburide should be avoided
Renal Insufficiency Blocks Ischemic Preconditioning
Thiazolidinediones (TZDs)
MAO: Enhance peripheral insulin sensitivity Cons:
Concerns for increased fluid retention Should not be used in setting of Hepatic Impairment
Case Example
70 y/o WM Hx of CAD, COPD, DM-2, HTN and obesity Admitted for Recurrent Pneumonia Current Meds: Metoprolol, Metformin 1000mg BID, Glyburide 5 mg daily, ASA, Lisinopril VS T 100.1, B/P 150/90, P 90, RR 24, Wt 250 lbs, Ht 58 Physical: Early peripheral neuropathy, no retinopathy LABS: WBC 15K, BG 250, HgA1c (3 months ago) 8.2 Cr 1.4 (baseline), BUN 28, Alb 2.7
Case continued
History what else do you want to know?
Diet at home I eat whatever I want! Recent change in medications? Glyburide was just added one month ago Hx of hypoglycemic episodes? NO Medication Compliance? I take whatever the give me Recent BG at home? When does he check? Creatinine Clearance?
ORDERS
Meds to stop BG monitoring Insulin orders
Wt in Kg Insulin Dosing
Insulin resistant vs. Insulin Naive? QID dosing
Sliding scale
ORDERS
250 lb = 114 kg Total Daily Dose of Insulin
114kg x 0.3 Units/kg/Day = 34 Units/Day
Goals of Treatment
Glycemic Control upper limits
Intensive Care 110 mg/dL Non-Critical Care
Preprandial 110 mg/dL Post-Prandial / MAX 180 mg/dl
American College of Endocrinology. Position Statement on Inpatient Diabetes and Metabolic Control. Endocr Pract 2004; 10:77-82
Low or no sugar diets are not acceptable Prompt Dietary consultation is recommended Remember D/C planning
Inpatient Education
Let your patient know what you have changed Educate on Symptoms of hypoglycemia Dietary Consultation Insulin education if new or different dose Close f/u as out-patient
D/C Planning
Try to have the patient on what will be his home medications / diet for at least 24 hours prior to D/C Close out-pt f/u Referral to Diabetes and Nutrition
Any admission with diabetes as an active issue qualifies Medicare for referral.
Goals
Review ADA goals for blood glucose levels Importance of maintaining euglycemia Discuss why ISS is not acceptable for sole coverage Give options for insulin regimens Discuss inpatient education Discharge planning
References
Abourizk, N., Inpatient Diabetology:The New Frontier, Journal General Internal Medicine, 19:466-471 American Diabetes Association, Translation of the Diabetes Nutrition Recommendations for Health Care Institutions, Diabetes Care 25: S1, S61-63 American Diabetes Association, American College of Endocrinology and American Diabetes Association Consensus Statement on Inpatient Diabetes and Glycemic Control, Diabetes Care, 29:1955-1962, 2006. Bloomgarden, Z., Inpatient Diabetes Control: Approaches to Treatment, Diabetes Care, 27:9, 2272-2277 Lien, L. In-hospital Management of Type 2 Diabetes Mellitus, Med Clin N Am, 88 (2004): 1085-1105 Moghissi, E, et. al, Hospital Management of Diabetes, Endocrinol Metab Clin N Am, 34 (2005): 99-116 Swift, C, et. al, Nutrition Care For Hospitalized Individuals with Diabetes, Diabetes Spectrum 18:1, 34-38